ADAMTS9-AS1在各种人类癌症中的双重作用:分子致病和临床影响
Haodong He1,2, Jingjie Yang1,2, Yan Zhou1,2
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, 443002, China.
长非编码RNAADAMTS9-AS1通过调节基因表达和信号通路,与各种癌症有关. 本次审查强调了其作为早期诊断生物标志物和瘤学治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 长非编码RNAs (lncRNAs) 调节基因表达和细胞功能.
- ADAMTS9-AS1,一个lncRNA,参与恶性瘤的进展.
- ADAMTS9-AS1作为一个ceRNA,调节miRNA相互作用和信号通路.
研究的目的:
- 审查最近在各种恶性瘤中对ADAMTS9-AS1的发现.
- 为了澄清ADAMTS9-AS1在癌症中的分子机制.
- 探索ADAMTS9-AS1在瘤学中的治疗潜力.
主要方法:
- 关于ADAMTS9-AS1和癌症的研究文献综述.
- 分析涉及ADAMTS9-AS1,miRNA和信号通路 (PI3K/AKT/mTOR,Wnt/β-catenin,Ras/MAPK) 的分子机制.
- 检查ADAMTS9-AS1在瘤发育,迁移,入侵和亡抵抗中的作用.
主要成果:
- ADAMTS9-AS1失调与瘤进展和转移有关.
- ADAMTS9-AS1影响关键的与癌症相关的信号通路.
- ADAMTS9-AS1参与了对亡机制的抵抗,包括铁诱导的亡.
结论:
- ADAMTS9-AS1 是不同类型癌症的重要因素.
- ADAMTS9-AS1具有作为早期诊断生物标志物的潜力.
- ADAMTS9-AS1为新型癌症干预提供了一个有希望的治疗点.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
12:14CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Non-Canonical Wnt Signaling Pathways
